Panizzon R, Stieger M, Schüler G, Hardmeier T
Schweiz Med Wochenschr. 1982 Apr 24;112(17):612-8.
A new subgroup of malignant melanoma, acral-lentiginous melanoma (ALM), is presented, which the authors have diagnosed in 8% of their melanoma patients. In a retrospective study the clinical and pathological findings in 44 patients with ALM are reviewed. A relationship was found between age, tumor diameter and thickness, pigmentation, ulceration, vasoinvasion and mitoses. The author's patients had a 5-year survival rate of 58%.
本文介绍了恶性黑色素瘤的一个新亚型——肢端雀斑样痣黑色素瘤(ALM),作者在其黑色素瘤患者中诊断出8%为此类型。在一项回顾性研究中,对44例肢端雀斑样痣黑色素瘤患者的临床和病理结果进行了回顾。发现年龄、肿瘤直径和厚度、色素沉着、溃疡、血管侵犯和有丝分裂之间存在关联。作者的患者5年生存率为58%。